Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_assertion type Assertion NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_head.
- NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_assertion description "[Pharmacogenetic testing of HTR2C promoter variants may be valuable when evaluating anti-obesity drugs which act directly or indirectly on the receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_provenance.
- NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_assertion evidence source_evidence_literature NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_provenance.
- NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_assertion SIO_000772 15048662 NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_provenance.
- NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_assertion wasDerivedFrom befree-20140225 NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_provenance.
- NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_assertion wasGeneratedBy ECO_0000203 NP185056.RA3hem8ixKmzSkf8-EyIdDeWrK3MF1szejOgPK3D5k6os130_provenance.